Virginia529 Hires Former Brightpoint Community College
Dr. Edward “Ted” Raspiller Will Lead Project Boosting Education Access through Statewide Mentorship, Scholarship and
Globe Newswire27-02-2023, 23:26
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00